Skip to main content
. 2016 Dec 31;6:259–268. doi: 10.1016/j.omtn.2016.12.009

Figure 6.

Figure 6

Lung Adenocarcinoma Histopathology

(A–D) H&E-stained slides at 400× magnification. Shown are (A) AKSLHN-treated, (B) combination-treated, (C) erlotinib-treated, and (D) PBS-treated lung adenocarcinomas.